Monitor for any further 13G amendments or a potential conversion to a 13D filing, which would signal activist intent. The reduction in stake by a passive investor following strong earnings is not inherently bearish but warrants watching for additional insider or institutional selling.
DCTH drugs
DCTH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $21.38entry
- T+1 · 4d ago −3.88%α −3.52% · $20.55
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Daniel Kaufman filed an amended Schedule 13G disclosing a reduced passive stake of 2.9% (1,016,524 shares) in Delcath Systems, down from the prior 6.3% stake reported by BlackRock in October 2026. The filing confirms Kaufman's continued passive investment without intent to influence control, and the reduction in stake size is notable given the company's recent strong Q3 earnings beat and raised guidance.
Key Financial Metrics
Key Facts
- Daniel Kaufman filed an amended Schedule 13G disclosing a 2.9% passive stake in Delcath Systems as of September 30, 2026.
- The stake consists of 1,016,524 shares of common stock.
- The prior 13G filing (October 27, 2026) by BlackRock disclosed a 6.3% stake, indicating a reduction in Kaufman's position.
- Kaufman certifies the securities were not acquired or held for the purpose of changing or influencing control of the issuer.
- The filing is an amendment to a prior Schedule 13G, not a new position.
Financial Impact
Kaufman's stake decreased from approximately 6.3% to 2.9%, representing a reduction of about 1,163,969 shares based on the prior BlackRock filing.
Risk Factors
- Reduction in passive stake could signal lack of conviction or portfolio rebalancing.
- No indication of activist intent; the filing remains passive.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001099910-26-000307 |
| Document: 0001099910-26-000307-index.html | 0001099910-26-000307 |
| Document: 0001099910-26-000307.txt | 0001099910-26-000307 |
Track record
12 reports on DCTH
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +27.22% at T+60 after the Feb 26, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Viewing Entry $21.38 Now $19.87 −7.06% settles Feb 10
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $20.27 Now $19.87 −1.97% settles Feb 5
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $14.82 Now $19.87 +34.08% settles Feb 2
- Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $14.86 Now $19.87 +33.71% settles Jan 26
- Oct 19, 202628d ago SC 13D/A Neutral 4/10 Entry $14.37 Now $19.87 +38.27% settles Jan 14
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $11.77 to $16.48 Now $19.87 +68.89% ▲ +40.08% +35.68% vs SPY
- May 14, 202626w ago 8-K Neutral 3/10 Entry $11.46 to $16.67 Now $19.87 +73.39% ▲ +45.46% +41.87% vs SPY
- May 7, 202627w ago 8-K Neutral 5/10 Entry $11.24 to $13.04 Now $19.87 +76.78% ▲ +16.01% +12.18% vs SPY
- Apr 2, 202632w ago DEFA14A Neutral 3/10 Entry $9.63 to $12.59 Now $19.87 +106.33% ▲ +30.74% +16.58% vs SPY
- Mar 2, 202637w ago Insider Cluster Bullish 6/10 Entry $8.93 to $10.83 Now $19.87 +122.51% ▲ +21.28% +11.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers